SteadyMed Ltd. (NASDAQ:STDY) reported 6/30/2017 earnings this N/A, coming in at ($0.33) per share, missing Wall Street’s estimates of ($0.32) per Share. Revenue for the quarter came in at $0.32 million beating analyst estimates of $0.26 million
Analyst Coverage For SteadyMed Ltd. (NASDAQ:STDY)
These are 2 Buy Ratings .
The current consensus rating for SteadyMed Ltd. (NASDAQ:STDY) is Buy (Score: 3.00) with a consensus target price of $16.00 , a potential (158.06% upside)Recent Insider Trading for SteadyMed Ltd. (NASDAQ:STDY)
- On 4/25/2017 Orbimed Advisors Llc, Major Shareholder, bought 1,174,000 with an average share price of $5.90 per share and the total transaction amounting to $6,926,600.00.
- On 8/4/2016 Keith Bank, Director, bought 266,257 with an average share price of $3.13 per share and the total transaction amounting to $833,384.41.
Recent Trading for SteadyMed Ltd. (NASDAQ:STDY) Shares of SteadyMed Ltd. closed the previous trading session at 6.20 down -0.12 -1.98% with 9,027 shares trading hands.